BioLineRx Ltd. (NASDAQ:BLRX) Q2 2025 Earnings Call Transcript August 14, 2025
BioLineRx Ltd. misses on earnings expectations. Reported EPS is $-1 EPS, expectations were $-0.35.
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] I would now like to turn over the call to Irina Koffler, Investor Relations Irina, please go ahead.
Irina Koffler: Thank you, operator, and welcome,...
